| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
68,231 |
52,650 |
$9.91M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,894 |
32,073 |
$306K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,211 |
11,110 |
$93K |
| 96127 |
|
5,901 |
5,085 |
$69K |
| 3008F |
|
2,417 |
1,913 |
$60K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,618 |
7,891 |
$33K |
| 90686 |
|
955 |
889 |
$28K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,054 |
1,777 |
$25K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,549 |
1,296 |
$21K |
| 81002 |
|
1,422 |
1,241 |
$19K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,098 |
1,005 |
$15K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,538 |
1,005 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,199 |
1,090 |
$13K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
981 |
850 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,649 |
1,313 |
$11K |
| 82948 |
|
231 |
218 |
$10K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
817 |
652 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
177 |
170 |
$8K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
488 |
437 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
342 |
315 |
$6K |
| 90832 |
Psychotherapy, 30 minutes with patient |
405 |
321 |
$6K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
264 |
233 |
$5K |
| 90715 |
|
198 |
187 |
$5K |
| 81025 |
|
309 |
270 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
144 |
136 |
$4K |
| 3044F |
|
121 |
101 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,619 |
2,109 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
139 |
114 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
90 |
82 |
$3K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
52 |
50 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
540 |
427 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
356 |
320 |
$3K |
| 3045F |
|
29 |
25 |
$2K |
| 90649 |
|
64 |
64 |
$2K |
| 90734 |
|
90 |
86 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,402 |
1,329 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
162 |
129 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
59 |
54 |
$992.52 |
| 90670 |
|
13 |
13 |
$970.98 |
| 90633 |
|
28 |
28 |
$917.78 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
332 |
241 |
$881.60 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
49 |
37 |
$777.48 |
| 90632 |
|
34 |
30 |
$755.82 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
32 |
26 |
$653.48 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
61 |
57 |
$298.23 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,997 |
2,292 |
$264.99 |
| Q3014 |
Telehealth originating site facility fee |
43 |
42 |
$239.68 |
| 0012A |
|
13 |
13 |
$80.00 |
| 83037 |
|
54 |
54 |
$38.79 |
| 99406 |
|
606 |
544 |
$0.00 |
| 3074F |
|
171 |
163 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
36 |
28 |
$0.00 |
| 90688 |
|
62 |
58 |
$0.00 |
| 3079F |
|
42 |
40 |
$0.00 |
| 1036F |
|
194 |
181 |
$0.00 |
| 90677 |
|
16 |
16 |
$0.00 |
| 90656 |
|
24 |
24 |
$0.00 |
| 87428 |
|
111 |
110 |
$0.00 |
| 90651 |
|
14 |
13 |
$0.00 |
| T1503 |
Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit |
14 |
14 |
$0.00 |
| 90837 |
Psychotherapy, 53 minutes with patient |
790 |
457 |
$0.00 |
| 87420 |
|
75 |
47 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
41 |
32 |
$0.00 |
| 3078F |
|
131 |
123 |
$0.00 |
| 90621 |
|
15 |
14 |
$0.00 |